What is the first line treatment for Neurocysticercosis (Viable Cysts)?

The first line treatment for neurocysticercosis that involves viable cysts is appropriately represented by the combination of albendazole (and/or praziquantel) along with corticosteroids. In cases of neurocysticercosis, treatment aims to both kill the cysticerci and manage the inflammation that occurs as a result of their death.

Albendazole and praziquantel are antihelmintic medications used to target the cysts. Albendazole is particularly effective and is often the preferred choice due to its efficacy in reducing the number of viable cysts and preventing complications. However, the use of corticosteroids is crucial as these reduce the inflammatory response that can occur when the cysts begin to die and break down, which may lead to complications such as seizures or increased intracranial pressure.

Using corticosteroids alongside the anthelmintics helps manage these inflammatory responses and makes treatment safer and more effective. This combined approach is standard practice in the management of neurocysticercosis, particularly when dealing with viable cysts, making this option the best choice among those listed.

Other treatments listed, like diethylcarbamazine, are primarily used for different parasitic infections and septic shock management is not applicable in the context